Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy.

Young D, Fong DM, Lawlor PA, Wu A, Mouravlev A, McRae M, Glass M, Dragunow M, During MJ.

Gene Ther. 2014 Dec;21(12):1029-40. doi: 10.1038/gt.2014.82. Epub 2014 Sep 18.

2.

Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates.

Lawlor PA, Bland RJ, Mouravlev A, Young D, During MJ.

Mol Ther. 2009 Oct;17(10):1692-702. doi: 10.1038/mt.2009.170. Epub 2009 Jul 28.

3.

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.

Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, Bland RJ, Young D, Strybing K, Eidelberg D, During MJ.

Lancet. 2007 Jun 23;369(9579):2097-105.

PMID:
17586305
4.

Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Abeta levels.

Lawlor PA, Bland RJ, Das P, Price RW, Holloway V, Smithson L, Dicker BL, During MJ, Young D, Golde TE.

Mol Neurodegener. 2007 Jun 9;2:11.

5.

Gene therapy for Parkinson's disease.

Lawlor PA, During MJ.

Expert Rev Mol Med. 2004 Mar 2;6(5):1-18. Review.

PMID:
15000692
6.

An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy.

During MJ, Symes CW, Lawlor PA, Lin J, Dunning J, Fitzsimons HL, Poulsen D, Leone P, Xu R, Dicker BL, Lipski J, Young D.

Science. 2000 Feb 25;287(5457):1453-60.

7.

Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective.

Young D, Lawlor PA, Leone P, Dragunow M, During MJ.

Nat Med. 1999 Apr;5(4):448-53.

PMID:
10202938
8.

Expression of Fos, Jun, and Krox family proteins in Alzheimer's disease.

MacGibbon GA, Lawlor PA, Walton M, Sirimanne E, Faull RL, Synek B, Mee E, Connor B, Dragunow M.

Exp Neurol. 1997 Oct;147(2):316-32.

PMID:
9344557
9.

Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus.

MacGibbon GA, Lawlor PA, Sirimanne ES, Walton MR, Connor B, Young D, Williams C, Gluckman P, Faull RL, Hughes P, Dragunow M.

Brain Res. 1997 Mar 7;750(1-2):223-34.

PMID:
9098548
10.

Differential expression of inducible transcription factors in basal ganglia neurons.

MacGibbon GA, Lawlor PA, Hughes P, Young D, Dragunow M.

Brain Res Mol Brain Res. 1995 Dec 28;34(2):294-302.

PMID:
8750832
11.
12.

Correlations between immediate early gene induction and the persistence of long-term potentiation.

Abraham WC, Mason SE, Demmer J, Williams JM, Richardson CL, Tate WP, Lawlor PA, Dragunow M.

Neuroscience. 1993 Oct;56(3):717-27.

PMID:
8255430
13.

Differential expression of immediate early genes after hippocampal long-term potentiation in awake rats.

Demmer J, Dragunow M, Lawlor PA, Mason SE, Leah JD, Abraham WC, Tate WP.

Brain Res Mol Brain Res. 1993 Mar;17(3-4):279-86.

PMID:
8510500
14.

Accumulation of calcitonin-gene related peptide-like immunoreactivity after hypoxic-ischaemic brain injury in the infant rat.

Dragunow M, Sirimanne E, Lawlor PA, Williams C, Gluckman P.

Brain Res Mol Brain Res. 1992 Jul;14(3):267-72.

PMID:
1331653
15.

Correlation between the induction of an immediate early gene, zif/268, and long-term potentiation in the dentate gyrus.

Richardson CL, Tate WP, Mason SE, Lawlor PA, Dragunow M, Abraham WC.

Brain Res. 1992 May 15;580(1-2):147-54.

PMID:
1504794

Supplemental Content

Loading ...
Support Center